… of care for patients with fever and neutropenia (FN) during chemotherapy for cancer. We
systematically reviewed the association between time to antibiotics (TTA) and clinical outcomes. …

… that patients with cancer, neutropenia, and fever do not make up a … cancer carry heavy burdens
of morbidity from their cancers, … results may apply widely to other populations with cancer. …

… The power of this study according to its sample size was more than 87.5% ie, since the
power of the study > 80 then the results of this study can be dependable. The type of the data …

… We conclude that the clinical outcomes of this sample of ED patients with cancer
chemotherapy–associated FN are substantial, and poorer than those included in the prior study on …

… outcomes, a separate, blinded review was performed for all subjects who were outpatients
when fever and neutropenia occurred (for medical … comorbidity and uncontrolled cancer) and …

… Febrile neutropenia is an oncologic … febrile neutropenia may result in adverse outcomes.
Our study aims to determine time-to- antibiotic administration in patients with febrile neutropenia…

… in children with cancer, fever and neutropenia RVs are the most frequent detected agents
irrespective of their initial risk assessment for IBI. The clinical course and outcome of mixed …

… Intravenous immunoglobulin (IVIG) therapy is not indicated for patients with febrile neutropenia
as a consequence of chemotherapy. IVIG therapy has been used for autoimmune and …

… We aimed to assess the clinical features, aetiology and outcomes of bacteraemic
pneumonia in neutropenic cancer patients (NCP) in the current era of increasing antimicrobial …

… , the emergence of new clinical problems, and the availability … for fever and infection in
neutropenic patients with cancer; (ii) … the results of clinical trials in this field; and (iii) the results of …